Prof. Wei Gao and his California Institute of Technology colleagues have developed the EBCare mask. This innovative mask analyzes the wearer’s breath to assess health, focusing on biomarkers for chronic obstructive pulmonary disease, asthma, and post-COVID-19 conditions.
The mask operates by cooling exhaled breath through an evaporative and radiative system, condensing the moisture into liquid. This liquid then moves through microfluidic channels to a reservoir undergoing chemical analysis. The resulting data is sent wirelessly to a smartphone app, providing real-time health insights.
In clinical trials with asthma and COPD patients, the EBCare successfully detected critical markers like exhaled nitrite and ammonium levels, indicators of airway inflammation and kidney health, respectively. It also accurately measured blood alcohol levels, presenting a cheaper alternative to traditional breathalyzers.
Prof. Gao emphasized the mask’s cost-effectiveness, noting that mass production could lower the material costs to around one dollar. “These initial studies confirm our concept,” he remarked. “We aim to expand this technology to track various health markers, creating a comprehensive health-monitoring tool.” Their findings appear in the journal “Science.”
